Paper32150830
Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling.
Or CR and 5 others. Int J Mol Sci, 2020. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling. Papers, record 32150830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32150830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Colorectal Neoplasms | Major topic |
| Proto-Oncogene Proteins c-bcl-2 | Major topic |
| Pyrroles | Major topic |
| Survivin | Major topic |
| Wnt Proteins | Major topic |
| beta Catenin | Major topic |
| Biomarkers, Tumor | |
| Cell Proliferation | |
| Enzyme Inhibitors | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Indoles | |
| Tumor Cells, Cultured |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| TCVGH-NCHU1047603 | Taichung Veterans General Hospital and National Chung Hsing University | PubMed | ||
| TTMHH-107R0007 | Tungs' Taichung MetroHarbor Hospital | PubMed |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9515795 | Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. | Cancer Res | 1998 | https://conductscience.org/library/papers/9515795 | PubMed |
| 2 | 31631858 | Colorectal cancer. | Lancet | 2019 | https://conductscience.org/library/papers/31631858 | PubMed |
| 3 | 28382170 | Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer. | Theranostics | 2017 | https://conductscience.org/library/papers/28382170 | PubMed |
| 4 | 26950068 | The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization. | PLoS One | 2016 | https://conductscience.org/library/papers/26950068 | PubMed |
| 5 | 18041902 | Anticancer and immunosuppressive properties of bacterial prodiginines. | Future Microbiol | 2007 | https://conductscience.org/library/papers/18041902 | PubMed |
| 6 | 28413363 | Wnt Signaling and Colorectal Cancer. | Curr Colorectal Cancer Rep | 2017 | https://conductscience.org/library/papers/28413363 | PubMed |
| 7 | 31370269 | Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31370269 | PubMed |
| 8 | 9823313 | Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. | Cancer Res | 1998 | https://conductscience.org/library/papers/9823313 | PubMed |
| 9 | 26289750 | Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms. | Am J Physiol Cell Physiol | 2015 | https://conductscience.org/library/papers/26289750 | PubMed |
| 10 | 23515850 | An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies. | Core Evid | 2013 | https://conductscience.org/library/papers/23515850 | PubMed |
| 11 | 19133282 | Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines. | Toxicol Appl Pharmacol | 2009 | https://conductscience.org/library/papers/19133282 | PubMed |
| 12 | 30530050 | Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/30530050 | PubMed |
| 13 | 26585594 | Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26585594 | PubMed |
| 14 | 26918045 | Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies. | J Cancer | 2016 | https://conductscience.org/library/papers/26918045 | PubMed |
| 15 | 25192188 | Pan-Bcl-2 inhibitor obatoclax delays cell cycle progression and blocks migration of colorectal cancer cells. | PLoS One | 2014 | https://conductscience.org/library/papers/25192188 | PubMed |
| 16 | 22324354 | Obatoclax mesylate : pharmacology and potential for therapy of hematological neoplasms. | Expert Opin Investig Drugs | 2012 | https://conductscience.org/library/papers/22324354 | PubMed |
| 17 | 30563080 | Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30563080 | PubMed |
| 18 | 31323961 | Blockade of STAT3 Signaling Contributes to Anticancer Effect of 5-Acetyloxy-6,7,8,4'-Tetra-Methoxyflavone, a Tangeretin Derivative, on Human Glioblastoma Multiforme Cells. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31323961 | PubMed |
| 19 | 30875757 | Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30875757 | PubMed |
| 20 | 28035994 | Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/28035994 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41097339 | Targeting Anti-Apoptotic Bcl-2 Proteins with Triterpene-Heterocyclic Derivatives: A Combined Dual Docking and Molecular Dynamics Study. | Molecules | 2025 | https://conductscience.org/library/papers/41097339 | PubMed |
| 40730501 | Bufalin Suppresses Triple-Negative Breast Cancer Stem Cell Growth by Inhibiting the Wnt/β-Catenin Signaling Pathway. | J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/40730501 | PubMed |
| 40707448 | Inhibition of anti-apoptotic Bcl-2 family members promotes synergistic cell death with ER stress inducers by disrupting autophagy in glioblastoma. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40707448 | PubMed |
| 40546326 | Exploring the therapeutic potential of Premna barbata Wall. ex Schauer stem bark in colon cancer: apoptosis induction, cell cycle analysis, and in-silico insights. | In Silico Pharmacol | 2025 | https://conductscience.org/library/papers/40546326 | PubMed |
| 39289948 | Exploring the Insights on Exosomes and their Utility in Treating Ophthalmic Disease: Delving into the Clinical Approval and Present Trials. | Curr Drug Deliv | 2026 | https://conductscience.org/library/papers/39289948 | PubMed |
| 38733492 | A small molecule compound 759 inhibits the wnt/beta-catenin signaling pathway via increasing the Axin protein stability. | Med Oncol | 2024 | https://conductscience.org/library/papers/38733492 | PubMed |
| 38609879 | A prognostic model of idiopathic pulmonary fibrosis constructed based on macrophage and mitochondria-related genes. | BMC Pulm Med | 2024 | https://conductscience.org/library/papers/38609879 | PubMed |
| 38575922 | Crosstalk between metabolism and cell death in tumorigenesis. | Mol Cancer | 2024 | https://conductscience.org/library/papers/38575922 | PubMed |
| 38494866 | Targeted inhibition of colorectal cancer proliferation: The dual-modulatory role of 2,4-DTBP on anti-apoptotic Bcl-2 and Survivin proteins. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/38494866 | PubMed |
| 38256213 | Mcl-1 Protein and Viral Infections: A Narrative Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38256213 | PubMed |
| 37771436 | Cellular senescence: a double-edged sword in cancer therapy. | Front Oncol | 2023 | https://conductscience.org/library/papers/37771436 | PubMed |
| 37511611 | Sertindole, an Antipsychotic Drug, Curbs the STAT3/BCL-xL Axis to Elicit Human Bladder Cancer Cell Apoptosis In Vitro. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511611 | PubMed |
| 37375740 | Sesquiterpene Coumarin Ethers with Selective Cytotoxic Activities from the Roots of Ferula huber-morathii Peşmen (Apiaceae) and Unequivocal Determination of the Absolute Stereochemistry of Samarcandin. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37375740 | PubMed |
| 36902436 | Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902436 | PubMed |
| 36884140 | Phloretin induces G2/M arrest and apoptosis by suppressing the β-catenin signaling pathway in colorectal carcinoma cells. | Apoptosis | 2023 | https://conductscience.org/library/papers/36884140 | PubMed |
| 36800962 | A literature review of microRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer. | Respir Res | 2023 | https://conductscience.org/library/papers/36800962 | PubMed |
| 36613579 | Hispolon Methyl Ether, a Hispolon Analog, Suppresses the SRC/STAT3/Survivin Signaling Axis to Induce Cytotoxicity in Human Urinary Bladder Transitional Carcinoma Cell Lines. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36613579 | PubMed |
| 36579676 | Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review). | Int J Oncol | 2023 | https://conductscience.org/library/papers/36579676 | PubMed |
| 36430344 | Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430344 | PubMed |
| 36267746 | Krüppel-like factor 5 promotes the progression of oral squamous cell carcinoma via the baculoviral IAP repeat containing 5 gene. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/36267746 | PubMed |
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32150830
GET https://conductscience.org/api/papers/v1/32150830/references?page=2